MediWound Stock Forecast, Price & News

MediWound (NASDAQ:MDWD) Frequently Asked Questions

Is MediWound a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for MediWound in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" MediWound stock.
View analyst ratings for MediWound or view top-rated stocks.

How has MediWound's stock been impacted by COVID-19 (Coronavirus)?

MediWound's stock was trading at $2.31 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, MDWD stock has increased by 5.2% and is now trading at $2.43.
View which stocks have been most impacted by COVID-19.

When is MediWound's next earnings date?

MediWound is scheduled to release its next quarterly earnings announcement on Thursday, February 24th 2022.
View our earnings forecast for MediWound.

How were MediWound's earnings last quarter?

MediWound Ltd. (NASDAQ:MDWD) posted its quarterly earnings results on Tuesday, November, 16th. The biopharmaceutical company reported ($0.12) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.13) by $0.01. The biopharmaceutical company had revenue of $6.37 million for the quarter, compared to analyst estimates of $5.60 million. MediWound had a negative net margin of 44.58% and a negative trailing twelve-month return on equity of 332.31%. During the same quarter in the previous year, the firm posted ($0.07) earnings per share.
View MediWound's earnings history.

What price target have analysts set for MDWD?

3 Wall Street analysts have issued 12-month price objectives for MediWound's shares. Their forecasts range from $6.50 to $9.00. On average, they expect MediWound's share price to reach $7.50 in the next year. This suggests a possible upside of 208.6% from the stock's current price.
View analysts' price targets for MediWound or view top-rated stocks among Wall Street analysts.

Who are MediWound's key executives?

MediWound's management team includes the following people:

• Sharon Malka, Chief Executive Officer
• Boaz Gur-Lavie, Chief Financial Officer
• Lior Rosenberg, Chief Medical Officer
• Ety Klinger, Chief Research & Development Officer
• Roni Solomon, Vice President-Finance

Who are some of MediWound's key competitors?

Some companies that are related to MediWound include ChromaDex (CDXC), HEXO (HEXO), IM Cannabis (IMCC), FitLife Brands (FTLF), Natural Alternatives International (NAII), Mannatech (MTEX), Grove (GRVI), Bon Natural Life (BON), General Cannabis (CANN), Charlie's (CHUC), Charlie's (CHUCD), Glucose Health (GLUC), Nutra Pharma (NPHC), Happiness Biotech Group (HAPP) and Tauriga Sciences (TAUG).
View all of MDWD's competitors.

What other stocks do shareholders of MediWound own?

Based on aggregate information from My MarketBeat watchlists, some companies that other MediWound investors own include OPKO Health (OPK), Sorrento Therapeutics (SRNE), The Blackstone Group (BX), Dynavax Technologies (DVAX), Geron (GERN), Idera Pharmaceuticals (IDRA), Mastercard (MA), SCYNEXIS (SCYX), Vascular Biogenics (VBLT) and Wells Fargo & Company (WFC).

What is MediWound's stock symbol?

MediWound trades on the NASDAQ under the ticker symbol "MDWD."

How do I buy shares of MediWound?

Shares of MDWD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MediWound's stock price today?

One share of MDWD stock can currently be purchased for approximately $2.43.

How much money does MediWound make?

MediWound has a market capitalization of $66.19 million and generates $21.76 million in revenue each year. The biopharmaceutical company earns $-9.20 million in net income (profit) each year or ($0.40) on an earnings per share basis.

How many employees does MediWound have?

MediWound employs 75 workers across the globe.

What is MediWound's official website?

The official website for MediWound is www.mediwound.com.

Where are MediWound's headquarters?

MediWound is headquartered at 42 HAYARKON STREET, YAVNE L3, 8122745.

How can I contact MediWound?

MediWound's mailing address is 42 HAYARKON STREET, YAVNE L3, 8122745. The biopharmaceutical company can be reached via phone at 972779714100, via email at [email protected], or via fax at 972-77-971-4111.